Autoimmune hemolytic anemia in COVID-19 patients: A systematic review of 105 cases on clinical characteristics and outcomes
Clinical Immunology · 2025
DOI: 10.1016/j.clim.2025.110512 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Clinical Immunology, 2025. Verfasst von Mohammed Ayyad und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Rutgers New Jersey Medical School, Newark, NJ, USA. Electronic address: dr.mohammad.ayyad@gmail.com. Hauptthemen laut MEDLINE: Anemia, Hemolytic, Autoimmune, COVID-19. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 113 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
BACKGROUND: COVID-19 has been linked to autoimmune hemolytic anemia (AIHA), a rare but serious condition causing red blood cell destruction. This systematic review examines the clinical characteristics, management, and outcomes of AIHA in COVID-19 patients. METHODS: A systematic search of PubMed, CINAHL, and Scopus identified 85 studies encompassing 105 patients. Data on demographics, clinical features, and treatment outcomes were extracted. RESULTS: Of 1402 articles, 85 met inclusion criteria. Most patients were male (54.3 %) with a mean age of 50.6 years, predominantly from Asia (83.5 %). Cold agglutinin AIHA was most common (48.2 %). Presenting symptoms included fatigue, dyspnea, and fever. Steroids were the most effective treatment, used in 95 % of recovered cases. Mortality was 14.3 %, with 26.7 % of deaths directly related to AIHA. CONCLUSIONS: COVID-19 is associated with AIHA, often presenting with non-specific symptoms. Early recognition and prompt steroid therapy are critical for improving outcomes. Further research is needed to guide management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Rutgers New Jersey Medical School, Newark, NJ, USA. Electronic address: dr.mohammad.ayyad@gmail.com.
- Department of Medicine, Cleveland Clinic Fairview Hospital, Cleveland, OH, USA.
- Faculty of Medicine, Al-Quds University, Jerusalem, Palestine.
- Department of Medicine, Faculty of Medicine and Health Sciences, An-Najah National University, Nablus 00970, Palestine.
- Department of General Surgery, Brooklyn Hospital Center, Brooklyn, NY, USA.
- Department of Medicine, Rutgers New Jersey Medical School, Newark, NJ, USA.
Zitieren
APA
Ayyad, M., Abu Alya, W., Barabrah, A. M., Darawish, S. M., AlHabil, Y., MohammedAli, M., Nabilsi, M. Z., Asad, D., Ayasa, L. A., & Matassa, D. (2025). Autoimmune hemolytic anemia in COVID-19 patients: A systematic review of 105 cases on clinical characteristics and outcomes. Clinical Immunology. https://doi.org/10.1016/j.clim.2025.110512
Vancouver
Ayyad M, Abu Alya W, Barabrah AM, Darawish SM, AlHabil Y, MohammedAli M, et al. Autoimmune hemolytic anemia in COVID-19 patients: A systematic review of 105 cases on clinical characteristics and outcomes. Clinical Immunology. 2025. doi:10.1016/j.clim.2025.110512
BibTeX
@article{Ayyad2025,
author = {Ayyad, Mohammed and Abu Alya, Walaa and Barabrah, Anas Mufeed and Darawish, Sara Mohammed and AlHabil, Yazan and MohammedAli, Majdeddin and Nabilsi, Mustafa Zafer and Asad, Diya and Ayasa, Laith A and Matassa, Daniel},
title = {Autoimmune hemolytic anemia in COVID-19 patients: A systematic review of 105 cases on clinical characteristics and outcomes},
journal = {Clinical Immunology},
year = {2025},
doi = {10.1016/j.clim.2025.110512}
}
EUVIMED